End Stage Renal DiseasePeridialysisNCT02488200
Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis
An observational study of End Stage Renal Disease, run by Herlev Hospital at 1 site in Denmark.
Trial summary
The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered. 1. What factors influence unplanned DI? 2. Read more about this study
- Who is it for?
- Ages 1 month to 95 years
- Conditions the study is for
- End Stage Renal Disease
- How many people
- 1,400 participants
- Where
- 1 siteDenmark
- Study dates
- Jan 2015to Jan 2020
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month to 95 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with Chronic Kidney Disease Stage 5 WHO start dialysis therapy for ESRD
Who may be able to join
- All patients starting maintenance dialysis therapies at the participating centers
Who cannot join
- Africans
Trial locations and contacts
1 site in 1 country.
Denmark1 site, 1 recruiting
- Recruiting
Herlev Hospital
Herlev, 2730
James G Heaf, MD DMSc, +4535125361, heaf@dadlnet.dk
About this study
The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered.
- What factors influence unplanned DI?
- What factors influence choice of dialysis modality?
- What factors influence choice of dialysis access?
- Why do physicians start dialysis?
- What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?
Read the detailed description
Patients All patients starting active end stage renal disease (ESRD) treatment at the participating centres and their satellite centres.
No. Patients: 1000.
- Patients who have received their recent predialysis care at another centre can be included if the previous centre's notes are available, otherwise not.
- Patients receiving a preemptive transplant are included, even if the transplant is performed at another centre. A patient questionnaire is not required for these patients.
- Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR) calculation) Each patient is allocated a local identity number (1,2,3….). The local author keeps a registry of the true patient identity of each identity number for follow-up purposes. This registry is not to be used in any communication outside the centre.
Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is unknown whether the uremia is acute or chronic. There are two main groups:
- Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which can be discarded if the patient recovers renal function within three months.
- Acute kidney injury (AKI). Most of these patients will recover within three months, so the questionnaire can wait, and be filled in retrospectively for the few remaining patients.
Methods
- Each participating centre fills a Centre Questionnaire, see Table 1.
- All prescribing doctors fill in a voluntary Physician Questionnaire, see Table 4.
- The doctor prescribing the first dialysis fills in a Motivation Questionnaire, see Table 2.
- The local coordinator fills in a Patient Notes Review
- Birthday
- Sex
- Height and weight
- Renal diagnosis
- Comorbidity
- Date and creatinine at referral to nephrology dept.
- Date and creatinine 6 months before dialysis start
- Date and creatinine 3 months before dialysis start
- Date and creatinine at start of dialysis information/choice
- Date and creatinine at access prescription. Date and creatinine at access creation. If there are several attempts at access creation, the last attempt is registered. For unplanned dialysis start, this is often the same date as dialysis start.
- Date of dialysis start
- Following values before first dialysis: B-hemoglobin, p- creatinine, urea, potassium, calcium, phosphate, bicarbonate, albumin
- Initial dialysis modality (centre hemodialysis (HD)/Home HD/continuous ambulatory peritoneal dialysis (CAPD)/ automated peritoneal dialysis (APD))
- Type of start (Planned/unplanned)
- Reason for unplanned start (primary and (if appropriate) secondary).
- For hemodialysis patient (HD) patients, initial access (areteriovenous fisula (AVF)/arteriovenous graft (AVG) /tunneled central venous catheter (CVC)/temporary CVC)
- Modality after 3 months (Center HD/Home HD/CAPD/APD/regained function/Transplanted/Dead)
- Is the patient alive after 3 months Yes/No. If "No" Date of death.
- Is the patient alive after 6 months Yes/No.
- If "No" Date of death.Is the patient alive after 12 months Yes/No. If "No" Date of death.
- Was the patient transplanted after inclusion? If so, when?
Responsibilities National coordinators are responsible for translation of protocol to local language, and compliance with any necessary national regulatory requirements (data protection agency, ethical committee?) Local representatives: local coordination and follow-up. Patient notes review. Additional secretarial assistance, paid or unpaid, is permitted.
Definitions
ESRD
A patient has ESRD if any of the following:
- He receives a transplant
- The doctor "believes" that he has ESRD at first dialysis
- He has received >90 days dialysis
- If the doctor is in doubt whether the patient has acute or chronic renal failure, the patient is registered as soon as there is no doubt that the patient has ESRD For 3 \& 4, registration is performed retrospectively from the first dialysis day.
Planned dialysis
The patient's first dialysis is planned if:
- His first hemodialysis uses an AV fistula
- His first hemodialysis uses a permanent catheter as the patient's permanent access
- His first peritoneal dialysis is >6 days after catheter placement.
The patient's first dialysis is unplanned if:
- His first hemodialysis uses a temporary catheter
- His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
- His first peritoneal dialysis is <7 days after catheter placement.
Renal Diagnoses
- Shrunken Kidneys of unknown cause
- Glomerulonephritis
- Chronic interstitial nephropathy, chronic pyelonephritis and postrenal uremia
- Polycystic kidney disease
- Hypertensive/atherosclerotic renal disease
- Diabetic Nephropathy
- Other
Causes of unplanned dialysis
- Late referral
- Acute uremia
- Acute progression of chronic uremia
- Doubt about reversibility
- Clinical indication despite acceptable biochemistry
- Fistula problems
- Delayed planning (Controversial. I recommend dialysis planning at the latest when eGFR <15 ml/minute. Please use your own definition).
- Patient non-compliance
- Patient refused dialysis, but later changed his/her mind
Causes of PD modality
- Patient choice
- Cardiac insufficiency
- HD not possible
Causes of HD Modality
- Patient Choice
- Physically incapable of peritoneal dialysis (PD)
- Mentally incapable of PD
- Abdominal problems
- Wish for Home HD
- PD not considered
Table 1 Center Questionnaire
- Author:
- Centre Name:
- Centre type: University/Non-academic
- Approximate population covered:
- No. new ESRD patients/year
- How many of these
- Preemptive transplant (%)?
- PD (%)?
- HD (%)?
- What is the
- PD prevalence (no. patients)?
- HD prevalence?
- How many nephrology specialists?
- Does the department have an official policy concerning preferred initial modality:
- No
- PD first
- Home HD first
- Other (what?)
- Does the department have an official policy concerning when pretransplant investigations should be initiated? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when dialysis modality choice is made? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when AV fistulae/grafts are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when peritoneal dialysis catheters are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when chronic dialysis is prescribed? If so what? If not, is there unofficial consensus? What?
Table 2. Motivation Questionnaire
You have just prescribed this patient's first dialysis. If you do not believe that the patient's dialysis requirement is chronic, you do not have to fill in this form Put a "1" besides the primary reason for starting dialysis today. Put a "2" besides a (possible) secondary reason for starting dialysis today. Put a "X" besides any other reasons that have been important in influencing your decision to prescribe dialysis today.
Taste disturbances Pulmonary stasis Social (what?) Dyspnea Practical (what?) (e.g. catheter protection) Hypertension Pericarditis Oedema Biochemical Cardiac symptoms High Plasma-Creatinine Fatigue High Urea Anorexia Low glomerular filtration rate (GFR) Nausea/vomiting High Potassium Cachexia/weight loss Acidosis Itching Low calcium Insomnia High Calcium Depression High Phosphate Diarrhea Falling GFR Other (what?)
Table 4. Physician Questionnaire What is your age? What is your sex? Are you a nephrology specialist? How many years have you been a doctor? How many years have you been a nephrology specialist?
- Conditions
- End Stage Renal Disease
- Being tested
- No intervention
- Medical subject headings
- Kidney Failure, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
No intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of patients who start planned dialysis initiation as defined by the protocol
Planned dialysis
The patient's first dialysis is planned if:
- His first hemodialysis uses an AV fistula
- His first hemodialysis uses a permanent catheter as the patient's permanent access
- His first peritoneal dialysis is >6 days after catheter placement.
The patient's first dialysis is unplanned if:
- His first hemodialysis uses a temporary catheter
- His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
- His first peritoneal dialysis is <7 days after catheter placement.
Measured: 1 year
Secondary outcomes (3)
Death
Time to patient death
Measured: 1 year
Choice of dialysis modality
Centre HD, Home HD, CAPD or APD
Measured: 1 year
Choice of dialysis access
AVF, AVG, Temporary CVC, Tunneled CVC, or PD catheter
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2015 (estimated)
- Study startJan 2015
- Primary completionJan 2019 (estimated)
- Study completionJan 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End Stage Renal DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,400 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Herlev Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Odense University Hospital, Aarhus University Hospital Skejby, Zealand University Hospital, Holbaek Sygehus, Central Jutland Regional Hospital, Sonderborg Hospital, Skovde Hospital, Karolinska University Hospital, Lund University Hospital, Turku University Hospital, Pauls Stradins Clinical University Hospital, Tartu University Hospital, The Hospital of Vestfold, St. Olavs Hospital, Oslo University Hospital
- Responsible party
- Principal investigator, James heaf, Herlev Hospital
- Investigators
- James G Heaf, MD DMSc, Principal investigator, Herlev Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02488200
- Sponsor's protocol ID
- CRU ID 15002474
- Acronym
- Peridialysis
- Status last verified
- Feb 2018
- First submitted
- 13 Jun 2015
- Last updated
- 26 Feb 2018
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Feb 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis
- ClinicalTrials.gov ID
- NCT02488200
- Acronym / sponsor ID
- Peridialysis / CRU ID 15002474
- Conditions
- End Stage Renal Disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,400 participants (estimated)
- Lead sponsor
- Herlev HospitalUniversity, hospital or other
- Collaborators
- Odense University Hospital, Aarhus University Hospital Skejby, Zealand University Hospital, Holbaek Sygehus, Central Jutland Regional Hospital, Sonderborg Hospital, Skovde Hospital, Karolinska University Hospital, Lund University Hospital, Turku University Hospital, Pauls Stradins Clinical University Hospital, Tartu University Hospital, The Hospital of Vestfold, St. Olavs Hospital, Oslo University Hospital
- Study start
- Jan 2015
- Primary completion
- Jan 2019 (estimated)
- Study completion
- Jan 2020 (estimated)
- First posted
- 2 Jul 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered.
- What factors influence unplanned DI?
- What factors influence choice of dialysis modality?
- What factors influence choice of dialysis access?
- Why do physicians start dialysis?
- What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?
Detailed description
Patients All patients starting active end stage renal disease (ESRD) treatment at the participating centres and their satellite centres.
No. Patients: 1000.
- Patients who have received their recent predialysis care at another centre can be included if the previous centre's notes are available, otherwise not.
- Patients receiving a preemptive transplant are included, even if the transplant is performed at another centre. A patient questionnaire is not required for these patients.
- Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR) calculation) Each patient is allocated a local identity number (1,2,3….). The local author keeps a registry of the true patient identity of each identity number for follow-up purposes. This registry is not to be used in any communication outside the centre.
Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is unknown whether the uremia is acute or chronic. There are two main groups:
- Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which can be discarded if the patient recovers renal function within three months.
- Acute kidney injury (AKI). Most of these patients will recover within three months, so the questionnaire can wait, and be filled in retrospectively for the few remaining patients.
Methods
- Each participating centre fills a Centre Questionnaire, see Table 1.
- All prescribing doctors fill in a voluntary Physician Questionnaire, see Table 4.
- The doctor prescribing the first dialysis fills in a Motivation Questionnaire, see Table 2.
- The local coordinator fills in a Patient Notes Review
- Birthday
- Sex
- Height and weight
- Renal diagnosis
- Comorbidity
- Date and creatinine at referral to nephrology dept.
- Date and creatinine 6 months before dialysis start
- Date and creatinine 3 months before dialysis start
- Date and creatinine at start of dialysis information/choice
- Date and creatinine at access prescription. Date and creatinine at access creation. If there are several attempts at access creation, the last attempt is registered. For unplanned dialysis start, this is often the same date as dialysis start.
- Date of dialysis start
- Following values before first dialysis: B-hemoglobin, p- creatinine, urea, potassium, calcium, phosphate, bicarbonate, albumin
- Initial dialysis modality (centre hemodialysis (HD)/Home HD/continuous ambulatory peritoneal dialysis (CAPD)/ automated peritoneal dialysis (APD))
- Type of start (Planned/unplanned)
- Reason for unplanned start (primary and (if appropriate) secondary).
- For hemodialysis patient (HD) patients, initial access (areteriovenous fisula (AVF)/arteriovenous graft (AVG) /tunneled central venous catheter (CVC)/temporary CVC)
- Modality after 3 months (Center HD/Home HD/CAPD/APD/regained function/Transplanted/Dead)
- Is the patient alive after 3 months Yes/No. If "No" Date of death.
- Is the patient alive after 6 months Yes/No.
- If "No" Date of death.Is the patient alive after 12 months Yes/No. If "No" Date of death.
- Was the patient transplanted after inclusion? If so, when?
Responsibilities National coordinators are responsible for translation of protocol to local language, and compliance with any necessary national regulatory requirements (data protection agency, ethical committee?) Local representatives: local coordination and follow-up. Patient notes review. Additional secretarial assistance, paid or unpaid, is permitted.
Definitions
ESRD
A patient has ESRD if any of the following:
- He receives a transplant
- The doctor "believes" that he has ESRD at first dialysis
- He has received >90 days dialysis
- If the doctor is in doubt whether the patient has acute or chronic renal failure, the patient is registered as soon as there is no doubt that the patient has ESRD For 3 \& 4, registration is performed retrospectively from the first dialysis day.
Planned dialysis
The patient's first dialysis is planned if:
- His first hemodialysis uses an AV fistula
- His first hemodialysis uses a permanent catheter as the patient's permanent access
- His first peritoneal dialysis is >6 days after catheter placement.
The patient's first dialysis is unplanned if:
- His first hemodialysis uses a temporary catheter
- His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
- His first peritoneal dialysis is <7 days after catheter placement.
Renal Diagnoses
- Shrunken Kidneys of unknown cause
- Glomerulonephritis
- Chronic interstitial nephropathy, chronic pyelonephritis and postrenal uremia
- Polycystic kidney disease
- Hypertensive/atherosclerotic renal disease
- Diabetic Nephropathy
- Other
Causes of unplanned dialysis
- Late referral
- Acute uremia
- Acute progression of chronic uremia
- Doubt about reversibility
- Clinical indication despite acceptable biochemistry
- Fistula problems
- Delayed planning (Controversial. I recommend dialysis planning at the latest when eGFR <15 ml/minute. Please use your own definition).
- Patient non-compliance
- Patient refused dialysis, but later changed his/her mind
Causes of PD modality
- Patient choice
- Cardiac insufficiency
- HD not possible
Causes of HD Modality
- Patient Choice
- Physically incapable of peritoneal dialysis (PD)
- Mentally incapable of PD
- Abdominal problems
- Wish for Home HD
- PD not considered
Table 1 Center Questionnaire
- Author:
- Centre Name:
- Centre type: University/Non-academic
- Approximate population covered:
- No. new ESRD patients/year
- How many of these
- Preemptive transplant (%)?
- PD (%)?
- HD (%)?
- What is the
- PD prevalence (no. patients)?
- HD prevalence?
- How many nephrology specialists?
- Does the department have an official policy concerning preferred initial modality:
- No
- PD first
- Home HD first
- Other (what?)
- Does the department have an official policy concerning when pretransplant investigations should be initiated? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when dialysis modality choice is made? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when AV fistulae/grafts are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when peritoneal dialysis catheters are prescribed? If so what? If not, is there unofficial consensus? What?
- Does the department have an official policy concerning when chronic dialysis is prescribed? If so what? If not, is there unofficial consensus? What?
Table 2. Motivation Questionnaire
You have just prescribed this patient's first dialysis. If you do not believe that the patient's dialysis requirement is chronic, you do not have to fill in this form Put a "1" besides the primary reason for starting dialysis today. Put a "2" besides a (possible) secondary reason for starting dialysis today. Put a "X" besides any other reasons that have been important in influencing your decision to prescribe dialysis today.
Taste disturbances Pulmonary stasis Social (what?) Dyspnea Practical (what?) (e.g. catheter protection) Hypertension Pericarditis Oedema Biochemical Cardiac symptoms High Plasma-Creatinine Fatigue High Urea Anorexia Low glomerular filtration rate (GFR) Nausea/vomiting High Potassium Cachexia/weight loss Acidosis Itching Low calcium Insomnia High Calcium Depression High Phosphate Diarrhea Falling GFR Other (what?)
Table 4. Physician Questionnaire What is your age? What is your sex? Are you a nephrology specialist? How many years have you been a doctor? How many years have you been a nephrology specialist?
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 1 month to 95 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with Chronic Kidney Disease Stage 5 WHO start dialysis therapy for ESRD
Key inclusion criteria (1 listed)
- All patients starting maintenance dialysis therapies at the participating centers
Key exclusion criteria (1 listed)
- Africans
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionNo intervention | Other | – |
Primary outcome
Proportion of patients who start planned dialysis initiation as defined by the protocol
Time frame: 1 year
Planned dialysis The patient's first dialysis is planned if: 1. His first hemodialysis uses an AV fistula 2. His first hemodialysis uses a permanent catheter as the patient's permanent access 3. His first peritoneal dialysis is >6 days after catheter placement. The patient's first dialysis is unplanned if: 1. His first hemodialysis uses a temporary catheter 2. His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned. 3. His first peritoneal dialysis is <7 days after catheter placement.
3 secondary outcomes
Death
Time frame: 1 year
Choice of dialysis modality
Time frame: 1 year
Choice of dialysis access
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Feb 2018.
- Individual participant dataSharing planned: No
Related trials for End Stage Renal Disease
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingObservational study
Physical Impairments in Children With Chronic Renal Failure
Chronic Kidney Failure, Chronic Kidney Diseases
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James G Heaf, MD DMSc principal investigator
Herlev Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End Stage Renal Disease, run by Herlev Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 26 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact James G Heaf, MD DMSc (+4535125361, heaf@dadlnet.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of patients who start planned dialysis initiation as defined by the protocol (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2018.